WHO ICTRP trial
Adjunctive accelerated intermittent theta burst stimulation and depression…
CTRI/2024/11/076657 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/11/076657 |
|---|---|
| Public title | Adjunctive accelerated intermittent theta burst stimulation and depression: comparison of three days vs five days protocol. |
| Scientific title | Effect of three days vs five days adjunctive accelerated intermittent theta burst stimulation (aiTBS) on outcomes in patients with depression a randomized Controlled Open Label Interventional Trial - D-iTBS |
| Primary sponsor | Dr Surobhi Chatterjee |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: F321- Major depressive disorder, singleepisode, moderate |
| Interventions | Intervention1: 3 days accelerated intermittent theta burst stimulation (iTBS): 15 sessions or 3 days of adjuvant iTBS(27000 pulses) Control Intervention1: 5 days accelerated intermittent theta burst stimulation (aiTBS): 5 days or 25… |
| Registration date | Dec 11, 2024 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: